Novo Nordisk
NVO
$124.57
Share price
-1.26%
Change (1 day)
46.14%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
EPS for Novo Nordisk (NVO)
EPS in 2023 (TTM): $2.86
According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is $2.86. In 2022 the company made an earnings per share (EPS) of $2.17 an increase over its 2021 EPS that were of $1.99.
EPS history for Novo Nordisk from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $2.86 | 31.58% |
| 2022 | $2.17 | 9.01% |
| 2021 | $1.99 | 15.08% |
| 2020 | $1.73 | 14.83% |
| 2019 | $1.51 | -1.68% |
| 2018 | $1.53 | 4.96% |
| 2017 | $1.46 | 31.08% |
| 2016 | $1.11 | -10.33% |
| 2015 | $1.24 | 13.91% |
| 2014 | $1.09 | 4.03% |
| 2013 | $1.05 | -28.81% |
| 2012 | $1.47 | 108.9% |
| 2011 | $0.70 | 25.59% |
| 2010 | $0.56 | 35.01% |
| 2009 | $0.42 | -9.17% |
| 2008 | $0.46 | 61.35% |
| 2007 | $0.28 | 28.96% |
| 2006 | $0.22 | 25.63% |
| 2005 | $0.18 | 4.17% |
| 2004 | $0.17 | 13.55% |
| 2003 | $0.15 | 36.87% |
| 2002 | $0.11 | -6.99% |
| 2001 | $0.12 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $1.86 | -34.87% | 🇺🇸 USA |
 Eli Lilly LLY | $5.43 | 90.12% | 🇺🇸 USA |
 Sanofi SNY | $3.18 | 11.36% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $3.97 | 39.02% | 🇺🇸 USA |